United State

English

MedCity News

MedCity News

About: MedCity News is the leading online news source for the business of innovation in healthcare. We offer insight into what’s next and what matters with a mix of breaking news and analysis on startups, and established industry leaders, personalities, policies and the most important deals.
Contact Us: Email: breakingmedia@theygsgroup.com
Cleveland Clinic Taps Dyania Health to Speed Up Clinical Trials with AI

Cleveland Clinic Taps Dyania Health to Speed Up Clinical Trials with AI

A Judge Approved BCBS’ $2.8B Settlement. Why Some Providers Are Opting Out

A Judge Approved BCBS’ $2.8B Settlement. Why Some Providers Are Opting Out

Novo Nordisk Turns to Self-Replicating RNA Startup to Discover New Metabolic Medicines

Novo Nordisk Turns to Self-Replicating RNA Startup to Discover New Metabolic Medicines

Putting SDOH Data to Work for Systems and Patients

Putting SDOH Data to Work for Systems and Patients

The Top-Rated Suppliers of Lu-177 for Cancer Research

The Top-Rated Suppliers of Lu-177 for Cancer Research

Why Cybersecurity Is Now Central to the Patient Experience

Why Cybersecurity Is Now Central to the Patient Experience

EVERSANA, Waltz Health Merge to Create $6B Prescription Drug Company

EVERSANA, Waltz Health Merge to Create $6B Prescription Drug Company

European Commission Approval Gives Blood Cancer Patients a New Cell Therapy Option

European Commission Approval Gives Blood Cancer Patients a New Cell Therapy Option

CDC Director Ousted After Less Than a Month on the Job

CDC Director Ousted After Less Than a Month on the Job

Bringing Clinical Data Management to the Cloud

Bringing Clinical Data Management to the Cloud

How Can Hospital-at-Home Grow Outside the Nation’s Biggest Health Systems?

How Can Hospital-at-Home Grow Outside the Nation’s Biggest Health Systems?

The Role of RWD in Revolutionizing Clinical Trial Design

The Role of RWD in Revolutionizing Clinical Trial Design

Duke Spinout Launches Platform to Unite Care and Clinical Research

Duke Spinout Launches Platform to Unite Care and Clinical Research

Regeneron’s RNA Med for Muscle Disease Meets Trial Goals; FDA Filing Planned for Next Year

Regeneron’s RNA Med for Muscle Disease Meets Trial Goals; FDA Filing Planned for Next Year

Dreem Health Launches 3 Partnerships to Address Sleep Disorders

Dreem Health Launches 3 Partnerships to Address Sleep Disorders

With a New Take on an Old Schizophrenia Drug, LB Pharma Prepares IPO to Fund Phase 3 Test

With a New Take on an Old Schizophrenia Drug, LB Pharma Prepares IPO to Fund Phase 3 Test

Healthcare Price Transparency is Not Enough

Healthcare Price Transparency is Not Enough

On-Demand Relief: What IV Therapy Company Offers the Fastest Service?

On-Demand Relief: What IV Therapy Company Offers the Fastest Service?

Evaluating the Complexities of the Digital Operating Room

Evaluating the Complexities of the Digital Operating Room

Without Clear Strategy, CMS’ $50B Rural Hospital Fund Risks Falling Short

Without Clear Strategy, CMS’ $50B Rural Hospital Fund Risks Falling Short

Report: Member Satisfaction in MA Insurers Is Dropping Due to Lack of Trust

Report: Member Satisfaction in MA Insurers Is Dropping Due to Lack of Trust

FDA Suspends Valneva Vaccine’s License Following New Reports of Adverse Events

FDA Suspends Valneva Vaccine’s License Following New Reports of Adverse Events

The Top-Rated Assistive Devices for Children With Sensory Processing Disorders

The Top-Rated Assistive Devices for Children With Sensory Processing Disorders

Supporting the Whole Patient: The Psychological Value of Scalp Cooling in Breast Cancer Treatment

Supporting the Whole Patient: The Psychological Value of Scalp Cooling in Breast Cancer Treatment

Regulatory Shift Paves Way for AI-Driven Heart Disease Diagnosis

Regulatory Shift Paves Way for AI-Driven Heart Disease Diagnosis

The Critical Link: How Supporting Nurse Managers Can Help Nurses

The Critical Link: How Supporting Nurse Managers Can Help Nurses

First Therapy for Rare Tumor Is a Blockbuster Prospect, But Does Precigen Have the Cash to Make It Happen?

First Therapy for Rare Tumor Is a Blockbuster Prospect, But Does Precigen Have the Cash to Make It Happen?

Insurers are Pulling Back on MA. How Does this Affect Patients?

Insurers are Pulling Back on MA. How Does this Affect Patients?

AI Meets Care Transitions: How One Startup Is Seeking to Reduce Readmissions and Costs

AI Meets Care Transitions: How One Startup Is Seeking to Reduce Readmissions and Costs

After Wegovy’s Historic MASH Approval, What’s Next?

After Wegovy’s Historic MASH Approval, What’s Next?